Literature DB >> 8423339

The fate of anergic T cells in vivo.

K Migita1, A Ochi.   

Abstract

The kinetics of Staphylococcal enterotoxin B-(SEB) induced peripheral tolerance has been investigated. Ten days after SEB injection, thymectomized BALB/cByJ mice showed suppressed spleen cell proliferative responses to SEB. After 2 mo the SEB-specific response was partly recovered. Four months later the response of spleen cells of SEB-primed mice was comparable to those of control mice. The proportion of CD4+, V beta 8+ T cells was diminished in the tolerized mice and was not restored even after the response was recovered. Purified CD4+, V beta 8+ T cells from SEB-primed mice after 4 mo responded similarly to SEB as control CD4+, V beta 8+ T cells. These expressed a similar profile of surface markers compared with that of unprimed control cells, except a homing receptor was slightly lower. An experiment that addressed the possibility that non-anergic T cells expand over time and are in fact responsible for the recovery of the proliferative response showed that such events unlikely occur in vivo. Therefore, the data indicate that T cell anergy is reversible in vivo. It is also suggested that the challenge with superantigen results in neither clonal expansion nor specific CD4+, V beta 8+ T cell memory.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423339

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Mixed hematopoietic chimerism and transplantation tolerance.

Authors:  B Nikolic; M Sykes
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 2.  Role of superantigens in experimental arthritis.

Authors:  A Abdelnour; Y X Zhao; T Bremell; R Holmdahl; A Tarkowski
Journal:  Springer Semin Immunopathol       Date:  1996

3.  Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus.

Authors:  Z Grossman; A Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Reversal of mucosal tolerance by subcutaneous administration of interleukin-12 at the site of attempted sensitization.

Authors:  A M Claessen; B M von Blomberg; J De Groot; D A Wolvers; G Kraal; R J Scheper
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

5.  Induction of Immunosuppressive CD8+CD25+FOXP3+ Regulatory T Cells by Suboptimal Stimulation with Staphylococcal Enterotoxin C1.

Authors:  Juyeun Lee; Nogi Park; Joo Youn Park; Barbara L F Kaplan; Stephen B Pruett; Juw Won Park; Yong Ho Park; Keun Seok Seo
Journal:  J Immunol       Date:  2017-12-13       Impact factor: 5.422

6.  Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functions.

Authors:  B Metzler; D C Wraith
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

7.  Prevention of murine acute graft-versus-host disease by staphylococcal enterotoxin B treatment.

Authors:  K Takenaka; Y Fujiyama; A Andoh; T Sasaki; Y Amakata; H Matsubara; K Hodohara; T Bamba
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

8.  Immune deficiency following thermal trauma is associated with apoptotic cell death.

Authors:  J A Teodorczyk-Injeyan; M Cembrzynska-Nowak; S Lalani; W J Peters; G B Mills
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

9.  Superantigens anergize cytokine production but not cytotoxicity in vivo.

Authors:  A Sundstedt; M Dohlsten; G Hedlund; I Höidén; M Björklund; T Kalland
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

10.  Tolerance to staphylococcal enterotoxin B initiated Th1 cell differentiation in mice infected with Candida albicans.

Authors:  L Romani; P Puccetti; A Mencacci; R Spaccapelo; E Cenci; L Tonnetti; F Bistoni
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.